Health resource utilisation due to IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study)
A. Romero Ortiz (Granada, Spain), A. Villar (Barcelona, Spain), E. Cano-Jiménez (Lugo, Spain), M. Rodríguez-Nieto (Madrid, Spain), S. Armengol (Barcelona, Spain), A. Ramon (Barcelona, Spain), M. Morros (Barcelona, Spain)
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Session: Clinical aspects of idiopathic pulmonary fibrosis
Session type: E-poster session
Number: 762
Disease area: -
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Romero Ortiz (Granada, Spain), A. Villar (Barcelona, Spain), E. Cano-Jiménez (Lugo, Spain), M. Rodríguez-Nieto (Madrid, Spain), S. Armengol (Barcelona, Spain), A. Ramon (Barcelona, Spain), M. Morros (Barcelona, Spain). Health resource utilisation due to IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study). 762
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Economic impact of IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study) Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021
Characteristics and clinical management of IPF patients in Spain: prospective, observational, multicentric study (OASIS study). Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020
The Spanish national clinical audit on COPD exacerbations (eCOPD). Pilot study: selection of study subjects Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD Year: 2008
REALizing and improving management of COPD in China: A prospective observational study Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021
Quality of life and healthcare utilisation in cystic fibrosis: a multicentre study Source: Eur Respir J 2013; 41: 571-577 Year: 2013
An Italian, observational, multicentre trial to describe treatment management in COPD patients: Preliminary results of the MISTRAL study Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014
DuoResp Spiromax adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD (SPRINT) Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018
Adequacy of treatment in COPD patients referred to the emergency room for disease exacerbation: an Italian multicentre observational study (the COXER study) Source: Annual Congress 2008 - Management of COPD Year: 2008
General practice and office spirometry in asthma and COPD: preliminary data from the prospective, randomised, comparative ²SPACE² Italian study Source: Eur Respir J 2004; 24: Suppl. 48, 87s Year: 2004
An Italian, observational, multicenter trial to describe the therapeutic approach according to COPD GOLD guidelines during three years of observation: The MISTRAL study Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014
An Italian, observational, multicenter trial in female COPD patients: Preliminary data on the women reality in the MISTRAL study Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014
Costs and effects of structured COPD care – An observational, matched-cohort study Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care Year: 2013
Clinical Assessment of Glycopyrronium in COPD phenotypes and ACOS: Prospective, case control, observational study Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019
Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019 Year: 2020
Long-term survivalaccording to Czech clinical phenotypes of COPD- Czech multicentre research database of severe COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016
Protocol for the EARCO Registry: a pan-European observational study in patients with a1 -antitrypsin deficiency Source: ERJ Open Res, 6 (1) 00181-2019; 10.1183/23120541.00181-2019 Year: 2020
Risk of future exacerbations among COPD patients – a real-world register-based cohort study (AvoidEx) Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities Year: 2020
Development of a new prognosis index (BODS) in patients with COPD:a prospective cohort study Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018
Multi-centre research: The experience of a UK, Danish and Dutch qualitative study exploring the meaning of COPD and its exacerbations to patients Source: Eur Respir J 2003; 22: Suppl. 45, 66s Year: 2003
Improved outcomes in ex-smokers with COPD: a UK primary care observational cohort study Source: Eur Respir J, 49 (5) 1602114; 10.1183/13993003.02114-2016 Year: 2017